Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-10,676
Closed -$547K 98
2022
Q4
$547K Sell
10,676
-316
-3% -$15.2K 0.38% 48
2022
Q3
$481K Buy
10,992
+394
+4% +$19.1K 0.36% 47
2022
Q2
$556K Sell
10,598
-34
-0.3% -$1.73K 0.48% 38
2022
Q1
$550K Sell
10,632
-139
-1% -$7.21K 0.43% 39
2021
Q4
$554K Buy
+10,771
New +$534K 0.41% 36
2021
Q3
Sell
-6,615
Closed -$259K 92
2021
Q2
$259K Buy
+6,615
New +$257K 0.23% 70

Other funds holding PFE

FWG Holdings's PFE Position: Q1 2023 in Review

FWG Holdings sold out of Pfizer (PFE) in Q1 2023, closing a stake of 10,676 shares — an estimated $547K sold.

FWG Holdings first reported a position in PFE in Q2 2021 and held it in 6 quarters. The position peaked at $556K in Q2 2022. 3,102 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

  • FWG Holdings reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
  • FWG Holdings sold 10,676 Pfizer shares in Q1 2023, an estimated $547K.
  • FWG Holdings first reported a position in Pfizer in Q2 2021 and held it in 6 quarters.
  • FWG Holdings's Pfizer position peaked at $556K in Q2 2022.
  • 3,102 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on FWG Holdings's 13F filing for Q1 2023, filed 12 May 2023.